Soichi Tofukuji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Soichi Tofukuji has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Toshinori Nakayama
Department of Immunology, Graduate School of Medicine Chiba University Chiba Japan
7 shared publications Makoto Kuwahara
Department of Immunology, Graduate School of Medicine, Ehime University, Shitsukawa, Toon, Ehime 791-0295, Japan
6 shared publicationsMasakatsu Yamashita
Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan
4 shared publicationsAtsushi Onodera
Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan
3 shared publications- Hiroyuki Hosokawa
Department of Immunology, Tokai University School of Medicine, Isehara, Kanagawa, Japan
3 shared publications Junpei Suzuki
Laboratory of Medical Genomics, Department of Human Genome Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan
3 shared publications
Latest Publications
- 3 May 2017
- Published by Springer Nature in EMBO Reports
- Vol. 18 (6) , 885-893
Hyper‐reactive cloned mice generated by direct nuclear transfer of antigen‐specific CD4+ T cells
T‐cell receptor (TCR)‐transgenic mice have been employed for evaluating antigen‐response mechanisms, but their non‐endogenous TCR might induce immune response differently than the physiologically expressed TCR. Nuclear transfer cloning produces animals that retain the donor genotype in all tissues including germline and immune systems. Taking advantage of this feature, we generated cloned mice that carry endogenously rearranged TCR genes from antigen‐specific CD4+ T cells. We show that T cells of the cloned mice display distinct developmental pattern and antigen reactivity because of their endogenously pre‐rearranged TCRα (rTα) and TCRβ (rTβ) alleles. These alleles were transmitted to the offspring, allowing us to establish a set of mouse lines that show chronic‐type allergic phenotypes, that is, bronchial and nasal inflammation, upon local administrations of the corresponding antigens. Intriguingly, the existence of either rTα or rTβ is sufficient to induce in vivo hypersensitivity. These cloned mice expressing intrinsic promoter‐regulated antigen‐specific TCR are a unique animal model with allergic predisposition for investigating CD4+ T‐cell‐mediated pathogenesis and cellular commitment in immune diseases. Synopsis TCR‐transgenic mice are important tools to analyze antigen‐response mechanisms. This study describes the generation of antigen‐specific mice cloned from T cells, which exhibit rearranged TCR‐dependent antigen reactivity and allergic predispositions. Cloned mice were successfully generated from antigen‐specific CD4+ T cells. Rearranged TCRα/β were required for their heritable in vitro antigen reactivity. Mice with either rearranged TCRα or TCRβ develop allergic bronchial and nasal inflammation.
- 3 May 2017
- Published by Springer Nature in EMBO Reports
- Vol. 18 (6) , 885-893
Hyper‐reactive cloned mice generated by direct nuclear transfer of antigen‐specific CD4+ T cells
T‐cell receptor (TCR)‐transgenic mice have been employed for evaluating antigen‐response mechanisms, but their non‐endogenous TCR might induce immune response differently than the physiologically expressed TCR. Nuclear transfer cloning produces animals that retain the donor genotype in all tissues including germline and immune systems. Taking advantage of this feature, we generated cloned mice that carry endogenously rearranged TCR genes from antigen‐specific CD4+ T cells. We show that T cells of the cloned mice display distinct developmental pattern and antigen reactivity because of their endogenously pre‐rearranged TCRα (rTα) and TCRβ (rTβ) alleles. These alleles were transmitted to the offspring, allowing us to establish a set of mouse lines that show chronic‐type allergic phenotypes, that is, bronchial and nasal inflammation, upon local administrations of the corresponding antigens. Intriguingly, the existence of either rTα or rTβ is sufficient to induce in vivo hypersensitivity. These cloned mice expressing intrinsic promoter‐regulated antigen‐specific TCR are a unique animal model with allergic predisposition for investigating CD4+ T‐cell‐mediated pathogenesis and cellular commitment in immune diseases. Synopsis TCR‐transgenic mice are important tools to analyze antigen‐response mechanisms. This study describes the generation of antigen‐specific mice cloned from T cells, which exhibit rearranged TCR‐dependent antigen reactivity and allergic predispositions. Cloned mice were successfully generated from antigen‐specific CD4+ T cells. Rearranged TCRα/β were required for their heritable in vitro antigen reactivity. Mice with either rearranged TCRα or TCRβ develop allergic bronchial and nasal inflammation.
- 1 February 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (2) , AB61
Long-Lasting Effect of Allergen-Specific Sublingual Immunotherapy in a Murine Model of Japanese Cedar Pollinosis
- 1 February 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (2) , AB61
Long-Lasting Effect of Allergen-Specific Sublingual Immunotherapy in a Murine Model of Japanese Cedar Pollinosis
- Open Access
- 1 January 2017
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 150 (2) , 68-71
A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy
日本における花粉症の患者数は,およそ30%に上ると推定され,近年急速に増加している.唯一の根治療法としてアレルゲン免疫療法が国内でも注目されており,特に侵襲性の低い投与ルートで実施できる舌下免疫療法(sublingual immunotherapy:SLIT)が期待されているが,本治療法の普及や適正使用に向けて解決すべき課題も残されている.例えば,その作用メカニズムが十分に解明されていないこと,投与する抗原用量・治療期間と薬効強度にどのような関係性があるのか情報が少ないこと,或いは治療効果を予測・モニタリングできるバイオマーカーが同定されていないこと等である.そこで我々は,これらの解決を目指して,SLITの治療効果を評価することができ,尚且つ,バイオマーカーの探索やメカニズム解明を目的とした研究に有用な新規のスギ花粉症モデルマウスの構築を試みた.スギ花粉粗抽出物(Japanese cedar pollen extract:JC)の経鼻感作と連日暴露により鼻炎症状を誘発し,5週間の間隔を開けてJCの暴露を繰り返すことで,毎年春に繰り返すヒトのスギ花粉症を模したモデルを作製した.また,鼻炎発症後にスギ花粉によるSLIT(JC-SLIT)を行い,その治療効果及びJC-SLIT終了後の薬効持続を評価した.その結果,JC-SLIT群はコントロール群と比較して鼻炎症状が強く抑制され,本モデルでJC-SLITの薬効評価が可能であることを示した.さらにJC-SLIT終了から約2ヵ月後でもその薬効は持続し,JC-SLITが従来の対症療法薬では認められない寛解維持作用を有することを確認した.臨床で観察される薬物療法の特長を反映した本モデルは,SLITの研究に有用であると考えられた.
- 1 January 2017
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 150 (2) , 68-71
Open AccessA novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy
日本における花粉症の患者数は,およそ30%に上ると推定され,近年急速に増加している.唯一の根治療法としてアレルゲン免疫療法が国内でも注目されており,特に侵襲性の低い投与ルートで実施できる舌下免疫療法(sublingual immunotherapy:SLIT)が期待されているが,本治療法の普及や適正使用に向けて解決すべき課題も残されている.例えば,その作用メカニズムが十分に解明されていないこと,投与する抗原用量・治療期間と薬効強度にどのような関係性があるのか情報が少ないこと,或いは治療効果を予測・モニタリングできるバイオマーカーが同定されていないこと等である.そこで我々は,これらの解決を目指して,SLITの治療効果を評価することができ,尚且つ,バイオマーカーの探索やメカニズム解明を目的とした研究に有用な新規のスギ花粉症モデルマウスの構築を試みた.スギ花粉粗抽出物(Japanese cedar pollen extract:JC)の経鼻感作と連日暴露により鼻炎症状を誘発し,5週間の間隔を開けてJCの暴露を繰り返すことで,毎年春に繰り返すヒトのスギ花粉症を模したモデルを作製した.また,鼻炎発症後にスギ花粉によるSLIT(JC-SLIT)を行い,その治療効果及びJC-SLIT終了後の薬効持続を評価した.その結果,JC-SLIT群はコントロール群と比較して鼻炎症状が強く抑制され,本モデルでJC-SLITの薬効評価が可能であることを示した.さらにJC-SLIT終了から約2ヵ月後でもその薬効は持続し,JC-SLITが従来の対症療法薬では認められない寛解維持作用を有することを確認した.臨床で観察される薬物療法の特長を反映した本モデルは,SLITの研究に有用であると考えられた.
- 1 January 2015
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 38 (2) , 317-320
CCL17 Production by Mouse Langerhans Cells Stimulated with Staphylococcus aureus Cell Wall Components
Patients with atopic dermatitis (AD) show increased numbers of Th2 cells in their acute skin lesions and superficial skin colonization by Staphylococcus aureus. The purpose of this study was to clarify the effect of S. aureus cell wall components on Th2 chemokine production by murine Langerhans cells (LCs). Murine LCs were stimulated with peptidoglycan (PEG) and/or muramyldipeptide (MDP) for 24 or 48 h, and Th1 and Th2 chemokine production was investigated by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). PEG-stimulation of LCs induced production of the Th2 chemokine CCL17 and this was enhanced in the presence of interleukin (IL)-4. A low-molecular weight PEG fragment, MDP, did not induce CCL17 production by LCs. However, when LCs were stimulated with PEG in combination with MDP, PEG-induced CCL17 production was synergistically enhanced by MDP. Furthermore, PEG- and MDP-induced CCL17 production was enhanced to a greater extent in the presence of IL-4. These results suggest that S. aureus colonization in AD patients may enhance the Th2-prone immune response through upregulation of CCL17 production by LCs, which would occur as a result of simultaneous stimulation with PEG and MDP from S. aureus in a Th2 environment.
- 1 January 2015
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 38 (2) , 317-320
CCL17 Production by Mouse Langerhans Cells Stimulated with Staphylococcus aureus Cell Wall Components
Patients with atopic dermatitis (AD) show increased numbers of Th2 cells in their acute skin lesions and superficial skin colonization by Staphylococcus aureus. The purpose of this study was to clarify the effect of S. aureus cell wall components on Th2 chemokine production by murine Langerhans cells (LCs). Murine LCs were stimulated with peptidoglycan (PEG) and/or muramyldipeptide (MDP) for 24 or 48 h, and Th1 and Th2 chemokine production was investigated by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). PEG-stimulation of LCs induced production of the Th2 chemokine CCL17 and this was enhanced in the presence of interleukin (IL)-4. A low-molecular weight PEG fragment, MDP, did not induce CCL17 production by LCs. However, when LCs were stimulated with PEG in combination with MDP, PEG-induced CCL17 production was synergistically enhanced by MDP. Furthermore, PEG- and MDP-induced CCL17 production was enhanced to a greater extent in the presence of IL-4. These results suggest that S. aureus colonization in AD patients may enhance the Th2-prone immune response through upregulation of CCL17 production by LCs, which would occur as a result of simultaneous stimulation with PEG and MDP from S. aureus in a Th2 environment.
- Open Access
- 2 April 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3555
The Menin–Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis
Although CD4 T-cell senescence plays an important role in immunosenescence, the mechanism behind this process remains unclear. Here we show that T cell-specific Menin deficiency results in the premature senescence of CD4 T cells, which is accompanied by the senescence-associated secretory phenotype after antigenic stimulation and dysregulated cytokine production. Menin is required for the expansion and survival of antigen-stimulated CD4 T cells in vivo and acts by targeting Bach2, which is known to regulate immune homeostasis and cytokine production. Menin binds to the Bach2 locus and controls its expression through maintenance of histone acetylation. Menin binding at the Bach2 locus and the Bach2 expression are decreased in the senescent CD4 T cells. These findings reveal a critical role of the Menin-Bach2 pathway in regulating CD4 T-cell senescence and cytokine homeostasis, thus indicating the involvement of this pathway in the inhibition of immunosenescence.
- 2 April 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3555
Open AccessThe Menin–Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis
Although CD4 T-cell senescence plays an important role in immunosenescence, the mechanism behind this process remains unclear. Here we show that T cell-specific Menin deficiency results in the premature senescence of CD4 T cells, which is accompanied by the senescence-associated secretory phenotype after antigenic stimulation and dysregulated cytokine production. Menin is required for the expansion and survival of antigen-stimulated CD4 T cells in vivo and acts by targeting Bach2, which is known to regulate immune homeostasis and cytokine production. Menin binds to the Bach2 locus and controls its expression through maintenance of histone acetylation. Menin binding at the Bach2 locus and the Bach2 expression are decreased in the senescent CD4 T cells. These findings reveal a critical role of the Menin-Bach2 pathway in regulating CD4 T-cell senescence and cytokine homeostasis, thus indicating the involvement of this pathway in the inhibition of immunosenescence.
- Open Access
- 16 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e61785
A Novel Small Compound SH-2251 Suppresses Th2 Cell-Dependent Airway Inflammation through Selective Modulation of Chromatin Status at the Il5 Gene Locus
IL-5 is a key cytokine that plays an important role in the development of pathological conditions in allergic inflammation. Identifying strategies to inhibit IL-5 production is important in order to establish new therapies for treating allergic inflammation. We found that SH-2251, a novel thioamide-related small compound, selectively inhibits the differentiation of IL-5-producing Th2 cells. SH-2251 inhibited the induction of active histone marks at the Il5 gene locus during Th2 cell differentiation. The recruitment of RNA polymerase II, and following expression of the Th2 cell-specific intergenic transcripts around the Il5 gene locus was also inhibited. Furthermore, Th2 cell-dependent airway inflammation in mice was suppressed by the oral administration of SH-2251. Gfi1, a transcriptional repressor, was identified as a downstream target molecule of SH-2251 using a DNA microarray analysis. The Gfi1 expression dramatically decreased in SH-2251-treated Th2 cells, and the SH-2251-mediated inhibition of IL-5-producing Th2 cell differentiation was restored by transduction of Gfi1. Therefore, our study unearthed SH-2251 as a novel therapeutic candidate for allergic inflammation that selectively inhibits active histone marks at the Il5 gene locus.
- 16 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e61785
Open AccessA Novel Small Compound SH-2251 Suppresses Th2 Cell-Dependent Airway Inflammation through Selective Modulation of Chromatin Status at the Il5 Gene Locus
IL-5 is a key cytokine that plays an important role in the development of pathological conditions in allergic inflammation. Identifying strategies to inhibit IL-5 production is important in order to establish new therapies for treating allergic inflammation. We found that SH-2251, a novel thioamide-related small compound, selectively inhibits the differentiation of IL-5-producing Th2 cells. SH-2251 inhibited the induction of active histone marks at the Il5 gene locus during Th2 cell differentiation. The recruitment of RNA polymerase II, and following expression of the Th2 cell-specific intergenic transcripts around the Il5 gene locus was also inhibited. Furthermore, Th2 cell-dependent airway inflammation in mice was suppressed by the oral administration of SH-2251. Gfi1, a transcriptional repressor, was identified as a downstream target molecule of SH-2251 using a DNA microarray analysis. The Gfi1 expression dramatically decreased in SH-2251-treated Th2 cells, and the SH-2251-mediated inhibition of IL-5-producing Th2 cell differentiation was restored by transduction of Gfi1. Therefore, our study unearthed SH-2251 as a novel therapeutic candidate for allergic inflammation that selectively inhibits active histone marks at the Il5 gene locus.
- 1 July 2012
- Published by Springer Nature in Nature Immunology
- Vol. 13 (8) , 778-786
The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation
The mechanisms of TGF-β-mediated inhibition of TH2 differentiation remain unclear. Nakayama and colleagues show that TGF-β induces the transcription factor Sox4, which negatively regulates the transcription factor GATA-3 by two independent mechanisms. Sox4 is a transcription factor that regulates various developmental processes. Here we show that Sox4 was induced by TGF-β and negatively regulated the transcription factor GATA-3, the master regulator of function of T helper type 2 (TH2) cells, by two distinct mechanisms. First, Sox4 bound directly to GATA-3, preventing its binding to GATA-3 consensus DNA sequences. Second, Sox4 bound to the promoter region of the gene encoding interleukin 5 (IL-5), a TH2 cytokine, and prevented binding of GATA-3 to this promoter. TH2 cell–driven airway inflammation was modulated by alterations in Sox4 expression. Thus, Sox4 acted as a downstream target of TGF-β to inhibit GATA-3 function, TH2 differentiation and TH2 cell–mediated inflammation.
- 1 July 2012
- Published by Springer Nature in Nature Immunology
- Vol. 13 (8) , 778-786
The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation
The mechanisms of TGF-β-mediated inhibition of TH2 differentiation remain unclear. Nakayama and colleagues show that TGF-β induces the transcription factor Sox4, which negatively regulates the transcription factor GATA-3 by two independent mechanisms. Sox4 is a transcription factor that regulates various developmental processes. Here we show that Sox4 was induced by TGF-β and negatively regulated the transcription factor GATA-3, the master regulator of function of T helper type 2 (TH2) cells, by two distinct mechanisms. First, Sox4 bound directly to GATA-3, preventing its binding to GATA-3 consensus DNA sequences. Second, Sox4 bound to the promoter region of the gene encoding interleukin 5 (IL-5), a TH2 cytokine, and prevented binding of GATA-3 to this promoter. TH2 cell–driven airway inflammation was modulated by alterations in Sox4 expression. Thus, Sox4 acted as a downstream target of TGF-β to inhibit GATA-3 function, TH2 differentiation and TH2 cell–mediated inflammation.
- Open Access
- 15 May 2012
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 188 (10) , 4846-4857
Identification of a New Pathway for Th1 Cell Development Induced by Cooperative Stimulation with IL-4 and TGF-β
IL-4 plays an important role in the induction of Th2 and Th9 cells, as well as in the inhibition of Th1 cell generation. We show that a combination of IL-4 and TGF-β augments the development of Th1 cells that express CD103 (CD103+ Th1 cells) if IFN-γ is present. The T-box–containing transcription factor eomesodermin (Eomes) is preferentially expressed in CD103+ Th1 cells and is involved in IFN-γ production. The induction of T-bet during early T cell activation is essential for the formation of the active chromatin at both the Eomes and IFN-γ gene loci. TGF-β is required for the induction of Eomes and CD103, as well as the inhibition of Th2 cytokine expression. In addition, IL-4 induces Eomes transcription through activation of the Stat6-signaling pathway. IFN-γ–producing CD103+ Th1 cells are detected in the intraepithelial lymphocytes of normal mice, and their numbers significantly decrease in Tbet- and Stat6-deficient mice. To our knowledge, these results represent the first molecular mechanism of IL-4/TGF-β–dependent augmentation of Th1 cell generation and raise the possibility that IL-4 and TGF-β simultaneously enhance the Th1 cell-mediated immune responses under certain cytokine conditions.
- 15 May 2012
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 188 (10) , 4846-4857
Open AccessIdentification of a New Pathway for Th1 Cell Development Induced by Cooperative Stimulation with IL-4 and TGF-β
IL-4 plays an important role in the induction of Th2 and Th9 cells, as well as in the inhibition of Th1 cell generation. We show that a combination of IL-4 and TGF-β augments the development of Th1 cells that express CD103 (CD103+ Th1 cells) if IFN-γ is present. The T-box–containing transcription factor eomesodermin (Eomes) is preferentially expressed in CD103+ Th1 cells and is involved in IFN-γ production. The induction of T-bet during early T cell activation is essential for the formation of the active chromatin at both the Eomes and IFN-γ gene loci. TGF-β is required for the induction of Eomes and CD103, as well as the inhibition of Th2 cytokine expression. In addition, IL-4 induces Eomes transcription through activation of the Stat6-signaling pathway. IFN-γ–producing CD103+ Th1 cells are detected in the intraepithelial lymphocytes of normal mice, and their numbers significantly decrease in Tbet- and Stat6-deficient mice. To our knowledge, these results represent the first molecular mechanism of IL-4/TGF-β–dependent augmentation of Th1 cell generation and raise the possibility that IL-4 and TGF-β simultaneously enhance the Th1 cell-mediated immune responses under certain cytokine conditions.
- 1 November 2010
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 191 (3) , i8
STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance ofGATA3expression in T helper type 2 cells
- 1 November 2010
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 191 (3) , i8
STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance ofGATA3expression in T helper type 2 cells
- Open Access
- 18 October 2010
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 207 (11) , 2493-2506
STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells
Polycomb group (PcG) and trithorax group (TrxG) complexes exert opposing effects on the maintenance of the transcriptional status of the developmentally regulated Hox genes. In this study, we show that activation of STAT6 induces displacement of the PcG complex by the TrxG complex at the upstream region of the gene encoding GATA3, a transcription factor essential for T helper type 2 (Th2) cell differentiation. Once Th2 cells differentiate, TrxG complex associated with the TrxG component Menin binds to the whole GATA3 gene locus, and this binding is required for the long-term maintenance of expression of GATA3 and Th2 cytokine. Thus, STAT6-mediated displacement of PcG by the TrxG complex establishes subsequent STAT6-independent maintenance of GATA3 expression in Th2 cells via the recruitment of the Menin–TrxG complex.
- 18 October 2010
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 207 (11) , 2493-2506
Open AccessSTAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells
Polycomb group (PcG) and trithorax group (TrxG) complexes exert opposing effects on the maintenance of the transcriptional status of the developmentally regulated Hox genes. In this study, we show that activation of STAT6 induces displacement of the PcG complex by the TrxG complex at the upstream region of the gene encoding GATA3, a transcription factor essential for T helper type 2 (Th2) cell differentiation. Once Th2 cells differentiate, TrxG complex associated with the TrxG component Menin binds to the whole GATA3 gene locus, and this binding is required for the long-term maintenance of expression of GATA3 and Th2 cytokine. Thus, STAT6-mediated displacement of PcG by the TrxG complex establishes subsequent STAT6-independent maintenance of GATA3 expression in Th2 cells via the recruitment of the Menin–TrxG complex.